“ “ ن م ه ي ف ت خ ف ن ه و ي ي و س ا ذ إ ف ن م ه ي ف ت خ ف ن ه و ي ي و س ا ذ إ ف ن ي د ه سإج ل وا ع ق ف ي ح رو ن ي د ه سإج ل وا ع ق ف ي ح رو“ “ ص ص۷۲ ۷۲
ونفخت “ “ سويته ونفخت فإذا سويته فإذافقعوا روحي من فقعوا فيه روحي من فيه
ساجدين ساجدين له ““له۷۲۷۲ص ص
Mechanical Mechanical Ventilation in Ventilation in Severe Airflow Severe Airflow
ObstructionObstructionNabil Abouchala, MDNabil Abouchala, MD
ConsultantConsultant
Pulmonary & Critical Care MedicinePulmonary & Critical Care Medicine
[email protected]@yahoo.com
Chronic lung diseases Chronic lung diseases with airflow with airflow obstructionobstruction
Chronic lung diseases Chronic lung diseases with airflow with airflow obstructionobstruction
Asthma Emphysema Bronchitis
Potentially fatal Potentially fatal asthmaasthma
5000 deaths/yr in US5000 deaths/yr in US
Two variants:Two variants:– progressive worsening 1-3 daysprogressive worsening 1-3 days– ““sudden death”sudden death”
Risk factorsRisk factors– History of near fatal asthma/intubationsHistory of near fatal asthma/intubations– Frequent hospitals/EDs (> 2/year)Frequent hospitals/EDs (> 2/year)– Co-morbidities (CV, COPD. Psych, drug abuse)Co-morbidities (CV, COPD. Psych, drug abuse)– Frequent meds (>2 puffers/month)Frequent meds (>2 puffers/month)– Poor socioeconomic statusPoor socioeconomic status
Ventilation in Ventilation in COPD/AsthmaCOPD/Asthma
Ventilation in Ventilation in COPD/AsthmaCOPD/Asthma
Which Patients with Which Patients with COPD benefit from NIV ?COPD benefit from NIV ?
Which Patients with COPD Which Patients with COPD benefit from NIV ?benefit from NIV ?Hospital MortalityHospital Mortality
12%
2%
NNT 8
Which Patients with COPD Which Patients with COPD benefit from NIV ?benefit from NIV ?Hospital MortalityHospital Mortality
12%
2%
NNT 8
Which Patients with COPD Which Patients with COPD benefit from NIV ?benefit from NIV ?Hospital MortalityHospital Mortality
NNT 8
Target Treatment for Target Treatment for Maximum Benefit of NIV in Maximum Benefit of NIV in COPD ExacerbationsCOPD Exacerbations
Likely to improve
Severity Likely toFail NIV
Target group for NIV
Potential Benefit
Less severe
Higher pH
> 7.30
Very severe COPD exacerbation
Severe hypercapnia
(PCO2 > 90)
Severe acidemia
pH < 7.10
Ventilation in Ventilation in COPD/AsthmaCOPD/Asthma
Case presentationA 68-year-old man with COPD is brought to the
emergency room in severe respiratory distress. The man weighs 65 kg (143 lb). Arterial blood gases document severe respiratory acidosis (PaCO2 is 104 mm Hg; pH is 7.10). After providing tracheal intubation and sedation, you order positive pressure ventilation in the assist control (AC) mode.
The most appropriate ventilatory setting at this point:
RR TV Peak inspiratory(mL) flow rate (L/min)
_A. 28 600 40B. 16 1000 60C. 24 1000 80D. 10 500 80E. 30 400 40
Tidal ventilation
Lung volume
VT
FRC
VT
VEE
Time
VEI
I :E1:1
I : E1: 6
Air-trapping in Asthma/COPD Air-trapping in Asthma/COPD Patients on Mechanical Patients on Mechanical VentilationVentilation
Obstructive Airway Obstructive Airway DiseaseDisease
Beware of auto-PEEP!Beware of auto-PEEP!
Detrimental effects of autoPEEPDetrimental effects of autoPEEPTrigger with acute
exacerbation
Tachypnea (decreased I:E ratio)
Increased airway resistance
Increased work of breathing
Increased work of breathing
HyperinflationHyperinflation
autoPEEPautoPEEP
Decreased effectiveness of
inspiratory musclesIncreased oxygen cost of
breathingIncreased oxygen cost of
breathing
Respiratory muscle fatigueRespiratory
muscle fatigue
Excessive Inspiratory Excessive Inspiratory TimeTimeExcessive Inspiratory Excessive Inspiratory TimeTime
Inspiration
Expiration
NormalNormalPatientPatient
Time (sec)
Flo
w (
L/m
in)
Air TrappingAuto-PEEP
}
Increase WOB and “Fighting” of the ventilator
Case presentationA 35-yr-old male is admitted with severe bronchial asthma
requiring ventilatory support. He is fully sedated and paralyzed, on assist-control mechanical ventilation with a set rate of 15 breaths/min; tidal volume of 1000 mL, and an inspiratory flow rate of 60 L/min, which gives an inspiratory-expiratory (I:E) ratio of 1:3. He is not on any PEEP, and an end-expiratory hold maneuver reveals an auto PEEP of 15 cm H2O.
Which one of the following options is most effective in minimizing the auto-PEEP?
A. Decreasing the RR 12 /min, giving an I:E ratio of 1:4
B. Increasing the flow to 120 L/min, giving an I:E ratio of 1:7
C. Decreasing the tidal volume to 900 mL
D. Adding an external PEEP of 5 cm H2O
Auto-PEEPAuto-PEEP
15 2 0
AA
15 15 15
BB
Measurement of auto-PEEP by expiratory occlusion
Ventilation in Ventilation in COPD/AsthmaCOPD/Asthma
Pressure or Volume Pressure or Volume Mode?Mode?
VolumeVolume Predictable TVPredictable TV Peak-Plat gradientPeak-Plat gradient Monitor PlatMonitor Plat Better acidosis Better acidosis
controlcontrol
PressurePressure Minimise over-Minimise over-
distensiondistension Monitor Tidal Monitor Tidal
volumevolume Excess volumes as Excess volumes as
airway resistance airway resistance improvesimproves
Initial Ventilator Initial Ventilator SettingsSettings Inspiratory time 0.8 – 1.2 secsInspiratory time 0.8 – 1.2 secs RR 10-12RR 10-12 TV 6-8 ml/KgTV 6-8 ml/Kg Pplat < 30 cm H2OPplat < 30 cm H2O PEEP ??PEEP ??
Assessment of Assessment of HyperinflationHyperinflation
Assessment of Assessment of HyperinflationHyperinflation
Reducing Reducing HyperinflationHyperinflation
Reduce rateReduce rate Reduce tidal volumeReduce tidal volume Increase expiratory timeIncrease expiratory time
– Increase inspiratory flow rateIncrease inspiratory flow rate– Increased Peak Airway PressureIncreased Peak Airway Pressure
Monitor (Pplat)Monitor (Pplat) Tolerate increased CO2Tolerate increased CO2
(minimise dead space)(minimise dead space)
I : E1: 6
I : E1: 2
Hypotension after Hypotension after initiation of Mechanical initiation of Mechanical VentilationVentilation
Conversion to positive Conversion to positive intrathoracic pressureintrathoracic pressure– Decreased venous return, Decreased venous return,
cardiac outputcardiac output– Exacerbated by hypovolemiaExacerbated by hypovolemia
Auto-PEEP increases Auto-PEEP increases intrathoracic pressureintrathoracic pressure
Ventilation in Ventilation in COPD/AsthmaCOPD/Asthma
PplPpl
EPPEPP
Pel
PalvPalv
PaoPao
1010
10
+10
1010
10
00
Waterfall ConceptExternal & Internal PEEP
10
External PEEPExternal PEEP
Offload effects of PEEPiOffload effects of PEEPi– Waterfall theory PEEPi not additive until above Waterfall theory PEEPi not additive until above
critical closing pressure of airwaycritical closing pressure of airway Reduce inspiratory muscle loadReduce inspiratory muscle load Improve ventilator triggeringImprove ventilator triggering Excess level will increase hyperinflationExcess level will increase hyperinflation 80% of PEEPi can be matched without 80% of PEEPi can be matched without
increase PEEP totincrease PEEP tot ?? reduce hyperinflation by improving ?? reduce hyperinflation by improving
expirationexpiration
Titrating PEEP to PEEPiTitrating PEEP to PEEPi
until no missed trigger effortsuntil no missed trigger efforts Minimise inspiratory effortMinimise inspiratory effort
– ClinicallyClinically– Oesophageal pressure/CVPOesophageal pressure/CVP
Until increase in hyperinflationUntil increase in hyperinflation– Pplat on volume modesPplat on volume modes– Until TV reduces on Pressure controlUntil TV reduces on Pressure control
Titrating PEEP to PEEPiTitrating PEEP to PEEPi
Ventilation in Ventilation in COPD/AsthmaCOPD/Asthma
TheophyllineTheophylline
Administration of Administration of BronchodilatorsBronchodilators
Nebuliser or MDI?Nebuliser or MDI? Lung deposition of radiolabelled drug*Lung deposition of radiolabelled drug*
– MDI 5.6% v Nebuliser 1.2%MDI 5.6% v Nebuliser 1.2% Urinary excretion**Urinary excretion**
– MDI with spacer 38%MDI with spacer 38%– MDI in line 9%MDI in line 9%– Nebuliser 16%Nebuliser 16%
4-10 puffs MDI effective in reducing R4-10 puffs MDI effective in reducing RAWAW
Administration of Administration of BronchodilatorsBronchodilators
Nebuliser or MDI?Nebuliser or MDI? Lung deposition of radiolabelled drug*Lung deposition of radiolabelled drug*
– MDI 5.6%MDI 5.6% v Nebuliser 1.2% v Nebuliser 1.2% Urinary excretion**Urinary excretion**
– MDI with spacer 38%MDI with spacer 38%
– MDI in line 9%MDI in line 9%– Nebuliser 16%Nebuliser 16%
4-10 puffs4-10 puffs MDI effective in reducing R MDI effective in reducing RAWAW
* Chest 1999; 115:1653-1657* Chest 1999; 115:1653-1657**Am Rev Respir Dis 1990; 141:440–444**Am Rev Respir Dis 1990; 141:440–444
Outcome of Ventilation & Outcome of Ventilation & COPDCOPD
166 patients requiring MV166 patients requiring MV Median duration 4.1 daysMedian duration 4.1 days 9% required > 21 days ventilation9% required > 21 days ventilation Hospital mortality 28%Hospital mortality 28% 9% discharged with 9% discharged with
tracheostomy tracheostomy MV MV 60% of MV time spent weaning60% of MV time spent weaning
Nevins & Epstein Chest 2001;119:1840Nevins & Epstein Chest 2001;119:1840
Weaning and COPDWeaning and COPD
Weaning protocolsWeaning protocols Non Invasive ventilationNon Invasive ventilation External PEEP to offload PEEPiExternal PEEP to offload PEEPi Optimise cardiac functionOptimise cardiac function
– DiureticsDiuretics– ACE inhibitorsACE inhibitors
AcetazolamideAcetazolamide
Myopathy in AsthmaMyopathy in Asthma
Steroid myopathySteroid myopathy Muscle relaxantsMuscle relaxants Polyneuropathy of the critically illPolyneuropathy of the critically ill
Myopathy in AsthmaMyopathy in Asthma
Principles of managing the Principles of managing the ventilated patient with ventilated patient with obstructive lung diseaseobstructive lung disease